Amalgamated Bank’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Amalgamated Bank’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-7,454	Closed	-$1.29M	–	1384
2015 Q1	$1.29M	Buy	7,454 +254	+4%	+$37.3K	0.16%	129
2014 Q4	$828K	Buy	7,200 +33	+0.5%	+$4K	0.13%	171
2014 Q3	$1.12M	Buy	7,167 +67	+0.9%	+$9.71K	0.17%	118
2014 Q2	$876K	Sell	7,100 -84	-1%	-$9.29K	0.13%	160
2014 Q1	$744K	Sell	7,184 -50	-0.7%	-$5.12K	0.13%	172
2013 Q4	$651K	Buy	+7,234	New	+$577K	0.11%	212

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Amalgamated Bank's SLXP Position: Q2 2015 in Review

Amalgamated Bank sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 7,454 shares — an estimated $1.29M sold.

Amalgamated Bank first reported a position in SLXP in Q4 2013 and held it in 6 quarters. The position peaked at $1.29M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Amalgamated Bank reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Amalgamated Bank sold 7,454 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $1.29M.
Amalgamated Bank first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q4 2013 and held it in 6 quarters.
Amalgamated Bank's SALIX PHARMACEUTICALS LTD DEL position peaked at $1.29M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Amalgamated Bank's 13F filing for Q2 2015, filed 10 Jul 2015.